Completed
Docetaxel in Hormone Refractory Prostate Cancer (HRPC)[Weekly or 3weekly TAX + Prednisone in HRPC]
NCT00268710
- Conditions
- Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +7 more
- Locations
-
Not specified